Agilent Technologies, Inc. (NYSE: A), Santa Clara, CA – FDA Inspections
Inspection records and compliance data for Agilent Technologies, Inc. in Santa Clara, California. 2 FDA inspections on record, 1 Form 483, last inspected February 17, 2017. Publicly traded as NYSE: A.
This profile covers Agilent Technologies, Inc. based in Santa Clara, California, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected July 6, 2015. Last inspected February 17, 2017.
Most cited issue areas
- Lack of or inadequate complaint procedures1 inspection
- Lack of or inadequate procedures for labeling1 inspection
- Report of violation of the Act (see 803.52(e)(9))1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 17, 2017 | Not classified | Medical Devices & Rad Health · Compliance: Devices | 1007312 |
| July 6, 2015 | VAI | Medical Devices & Rad Health · Compliance: Devices | 936087 |
No Form 483s, Warning Letters or EIRs on record.
Companies with similar regulatory profiles, compliance history, and operations.
Name
Agilent Technologies, Inc.
Stock ticker
A
Exchange
NYSE
Share price
$171.66
Market cap
$48.4B
Price as of
November 6, 2026
FEI Number
2916205
Address
5301 Stevens Creek Blvd, Santa Clara, California 95051, United States
Country
United States
ID: 923cc556-27ac-40a7-b96d-e813aa42743b